Stay updated on Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial page.

Latest updates to the Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial page
- Check4 days agoChange DetectedThe record displays details for the ERA-HF trial investigating empagliflozin versus placebo for arrhythmic events in heart failure patients, including its study plan, eligibility criteria, outcome measures, and study documents.SummaryDifference51%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study-record error page.SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer’s revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content for NCT03271879. This blocks access to the study details and related information on the page.SummaryDifference19%

Stay in the know with updates to Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial page.